Gamma-glutamyl transferase predicts pemafibrate treatment response in non-alcoholic fatty liver disease.
Sign Up to like & getrecommendations! Published in 2023 at "Journal of gastroenterology and hepatology"
DOI: 10.1111/jgh.16222
Abstract: BACKGROUND AND AIM Pemafibrate, a selective peroxisome proliferator activated receptor α modulator, has been shown to improve liver function among nonalcoholic fatty liver disease (NAFLD) patients with dyslipidemia. The aim of this retrospective study is… read more here.
Keywords: fast score; ggt; fatty liver; nafld patients ... See more keywords
Symptom or faecal immunochemical test based referral criteria for colorectal cancer detection in symptomatic patients: a diagnostic tests study
Sign Up to like & getrecommendations! Published in 2018 at "BMC Gastroenterology"
DOI: 10.1186/s12876-018-0887-7
Abstract: BackgroundSymptom based referral criteria for colorectal cancer (CRC) detection are the cornerstone of the strategy to improve prognosis in CRC. In 2017, the National Institute for Health and Care Excellence (NICE) updated their referral criteria… read more here.
Keywords: fast score; referral criteria; 2017 ng12; test ... See more keywords
Validation of the accuracy of the FAST™ score for detecting patients with at-risk nonalcoholic steatohepatitis (NASH) in a North American cohort and comparison to other non-invasive algorithms
Sign Up to like & getrecommendations! Published in 2022 at "PLoS ONE"
DOI: 10.1371/journal.pone.0266859
Abstract: Background and aims Management of patients with NASH who are at elevated risk of progressing to complications of cirrhosis (at-risk NASH) would be enhanced by an accurate, noninvasive diagnostic test. The new FAST™ score, a… read more here.
Keywords: fast score; invasive algorithms; non invasive; accuracy ... See more keywords